A Pilot Study of Inflammatory Markers in Alzheimer's Disease

NCT00715858 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: doxycycline
DRUG: rifampin
DRUG: placebo

Sponsor

McMaster University

Collaborators

[object Object]